Picard Medical (PMI) FCF Margin (2024 - 2026)

Picard Medical posted quarterly FCF Margin of 332.7% for Q1 2026, up 2876.0% year-on-year from 11.18% in Q1 2025, and up 23.31% on a QoQ basis from 433.8% in Q4 2025.

Picard Medical (PMI) has 3 years of FCF Margin data on file, last reported at 332.7% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin rose 2876.0% year-over-year to 332.7%; the trailing twelve-month figure through Mar 2026 stood at 315.1% (down 5113.0% YoY), and the FY2025 full-year result was 317.27%, down 4685.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 332.7%, up from 433.8% in the prior quarter.
  • Across five years, FCF Margin topped out at 119.24% in Q2 2025 and bottomed at 548.78% in Q3 2025.
  • The 3-year median for FCF Margin is 361.45% (2025), against an average of 352.72%.
  • The widest annual swing landed in 2025, when FCF Margin sank 25275 bps; it then soared 2876 bps in 2026.
  • A 3-year view of FCF Margin shows it stood at 377.03% in 2024, then declined by 15 bps to 433.8% in 2025, then advanced by 23 bps to 332.7% in 2026.
  • The last three FCF Margin figures came in at 332.7% (Q1 2026), 433.8% (Q4 2025), and 548.78% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.89%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 25.51%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.29%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -1.28%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.68%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 37.67%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.98%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.44%
10 Picard Medical 12.10 Mn 12.10 Mn 275,000.00 -332.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -332.70%
Dec 31, 2025 -433.80%
Sep 30, 2025 -548.78%
Dec 31, 2024 -377.03%
Sep 30, 2024 -296.03%